Skip to main content
. 2018 May 10;13(4):266–274. doi: 10.1089/bfm.2017.0172

Table 1.

Timeline of Hospital-Level Initiatives to Improve the Care of Opioid-Exposed Mother-Infant Dyads

Time period Participation in addiction treatment program required Prenatal care requirements Urine toxicology requirements: number of weeks without aberrant testing before deliverya Breastfeeding eligibility guidelines and institution breastfeeding improvements
01/2006–12/2009 Yes None 12 • 2006 First Written Breastfeeding Guidelines
01/2010–12/2012 Yes ≥12 weeks before delivery, no more than two missed visits 10 • 2010 Revised Written Breastfeeding Guidelines
• 2010 Brochure on benefits of breastfeeding in OUD developed and distributed passively in prenatal clinic
01/2013–03/2015 Yes ≥12 weeks before delivery, no more than two missed visits 10 • 2013 NAS QI Committee formed; statewide QI collaborative started
• 2013–14 NAS QI Committee focuses on standardization of monitoring of NAS infants and early pharmacologic treatment
• Early 2015 NAS QI Committee reviewed breastfeeding guidelines
04/2015–12/2016 Yes Attendance at ≥50% or ≥5 prenatal visits 4 • April 2015 revised breastfeeding guidelines approved
• 04/2015 Started active face-to-face prenatal breastfeeding education
• 2015 NAS QI Committee focuses on: (1) skin-to-skin, (2) rooming-in, and (3) lactation support, after mothers are discharged, but infant still admitted.
a

Aberrant toxicology test defined as any nonprescribed opioids, benzodiazepines, amphetamines, or other illicit substances.

NAS, neonatal abstinence syndrome; OUD, opioid use disorder; QI, quality improvement.